Gross margin moved 172 bp higher
Gross margin changed +172 basis points from the comparable as-filed period.
45.06%→46.78%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CHD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash / debt moved 640 bp higher
Cash / debt changed +640 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
13.85%→20.25%4 prior comparisons
Operating income increased 14.5%
Operating income changed +14.5% from the comparable as-filed period.
$254.6M→$291.4M2 prior comparisons
Stock-based compensation increased 27.9%
Stock-based compensation changed +27.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$14.0M→$17.9M2 prior comparisons
Inventory / revenue moved 136 bp lower
Inventory / revenue changed -136 basis points from the comparable as-filed period.
40.83%→39.47%2 prior comparisons
Working capital / assets moved 227 bp lower
Working capital / assets changed -227 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.42%→-0.85%4 prior comparisons
Revenue increased 1.0%
Revenue changed +1.0% from the comparable as-filed period.
$1.6B→$1.6B2 prior comparisons
Working capital changed across a sign change
Working capital changed -161.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$129.7M→-$79.5M4 prior comparisons
Current assets increased 8.7%
Current assets changed +8.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.6B→$1.8B4 prior comparisons
Net debt decreased 7.3%
Net debt changed -7.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$1.8B4 prior comparisons
Capex / revenue moved 8 bp higher
Capex / revenue changed +8 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.78%→1.86%2 prior comparisons
Total assets increased 2.1%
Total assets changed +2.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$9.1B→$9.3B4 prior comparisons
Shares outstanding decreased 1.7%
Shares outstanding changed -1.7% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
240,130,071→236,032,0528 prior comparisons
SBC / revenue moved 23 bp higher
SBC / revenue changed +23 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.88%→1.12%2 prior comparisons
Debt / revenue moved 128 bp lower
Debt / revenue changed -128 basis points from the comparable as-filed period.
139.03%→137.75%2 prior comparisons
Trade receivables increased 4.9%
Trade receivables changed +4.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$605.7M→$635.2M4 prior comparisons
Current ratio decreased 11.9%
Current ratio changed -11.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.09→0.964 prior comparisons
Cost of revenue decreased 2.1%
Cost of revenue changed -2.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$871.2M→$852.7M2 prior comparisons
Receivables / revenue moved 145 bp higher
Receivables / revenue changed +145 basis points from the comparable as-filed period.
38.20%→39.65%2 prior comparisons
Capital expenditure increased 5.7%
Capital expenditure changed +5.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$28.2M→$29.8M2 prior comparisons
Research & development increased 0.6%
Research & development changed +0.6% from the comparable as-filed period.
$36.2M→$36.4M2 prior comparisons
Debt / assets moved 48 bp lower
Debt / assets changed -48 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
24.11%→23.63%4 prior comparisons
Selling, general & administrative increased 4.0%
Selling, general & administrative changed +4.0% from the comparable as-filed period.
$256.9M→$267.3M2 prior comparisons
Gross profit increased 4.9%
Gross profit changed +4.9% from the comparable as-filed period.
$714.4M→$749.4M2 prior comparisons
R&D / revenue moved 1 bp lower
R&D / revenue changed -1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.28%→2.27%2 prior comparisons
Inventory decreased 2.3%
Inventory changed -2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$647.4M→$632.3M4 prior comparisons
Reported total debt increased 0.1%
Reported total debt changed +0.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
Gross debt increased 0.1%
Gross debt changed +0.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
Current ratio decreased 37.9%
Current ratio changed -37.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.84→1.154 prior comparisons
Inventory / revenue moved 198 bp lower
Inventory / revenue changed -198 basis points from the comparable as-filed period.
41.32%→39.34%2 prior comparisons
Shares outstanding decreased 2.6%
Shares outstanding changed -2.6% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
243,608,695→237,203,9078 prior comparisons
Operating margin moved 69 bp higher
Operating margin changed +69 basis points from the comparable as-filed period.
17.37%→18.07%2 prior comparisons
Capital expenditure increased 32.9%
Capital expenditure changed +32.9% from the comparable as-filed period.
$22.5M→$29.9M3 prior comparisons
Stock-based compensation increased 77.9%
Stock-based compensation changed +77.9% from the comparable as-filed period.
$9.5M→$16.9M3 prior comparisons
Revenue increased 1.6%
Revenue changed +1.6% from the comparable as-filed period.
$1.5B→$1.5B2 prior comparisons
Debt / revenue moved 224 bp lower
Debt / revenue changed -224 basis points from the comparable as-filed period.
146.44%→144.20%2 prior comparisons
Capex / revenue moved 46 bp higher
Capex / revenue changed +46 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.49%→1.95%2 prior comparisons
Operating income increased 5.6%
Operating income changed +5.6% from the comparable as-filed period.
$261.7M→$276.4M2 prior comparisons
Current liabilities increased 9.8%
Current liabilities changed +9.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.2B→$1.3B4 prior comparisons
SBC / revenue moved 47 bp higher
SBC / revenue changed +47 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.63%→1.10%2 prior comparisons
Total assets increased 3.6%
Total assets changed +3.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.8B→$9.1B4 prior comparisons
Selling, general & administrative increased 10.5%
Selling, general & administrative changed +10.5% from the comparable as-filed period.
$228.2M→$252.2M2 prior comparisons
Research & development decreased 5.3%
Research & development changed -5.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$35.8M→$33.9M2 prior comparisons
Receivables / revenue moved 156 bp lower
Receivables / revenue changed -156 basis points from the comparable as-filed period.
40.56%→39.01%2 prior comparisons
Cost of revenue decreased 2.7%
Cost of revenue changed -2.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$859.3M→$836.1M2 prior comparisons
Debt / assets moved 87 bp lower
Debt / assets changed -87 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
25.10%→24.23%4 prior comparisons
Inventory decreased 3.3%
Inventory changed -3.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$622.4M→$601.9M4 prior comparisons
Gross profit increased 7.2%
Gross profit changed +7.2% from the comparable as-filed period.
$647.0M→$693.9M2 prior comparisons
R&D / revenue moved 16 bp lower
R&D / revenue changed -16 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.38%→2.22%2 prior comparisons
Trade receivables decreased 2.3%
Trade receivables changed -2.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$611.0M→$596.8M4 prior comparisons
Gross debt increased 0.0%
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
Noncurrent long-term debt increased 0.0%
Noncurrent long-term debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
Reported total debt increased 0.0%
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.